Research on Partially Hydrolyzed Whey Formula and Infant Allergies

Introduction to Infant Allergies

Researchers are investigating a partially hydrolyzed 100% whey formula (pHF) produced by Swiss company Nestlé to assess its potential in reducing allergy risks, such as eczema and asthma, in infants. Allergies can be distressing for both infants and their parents, as conditions like eczema often cause significant discomfort, leading to scratching and irritability. Infant eczema, or atopic dermatitis, results in itchy and rough skin.

Study Overview

The World Allergy Organization Journal published this pivotal study on July 26, 2017. This meta-analysis evaluated data from eight previous clinical trials, encompassing nearly 2,000 infants up to one year old from industrialized nations. The duration of these trials ranged from three to twelve months, with some participants followed for up to 15 years.

Focus on Nestlé’s Formula

While many pHF formulas are available, the researchers concentrated on Nestlé’s specific product for their analysis. They emphasized the importance of examining a single formula to maintain consistency across their meta-data analysis, as different pHF products can vary in ingredients.

Findings on Allergy Prevention

The results indicate that infants who consumed the pHF were less likely to experience allergies during childhood and their teenage years compared to those fed cow’s milk formulas. The researchers engaged with authors of prior studies to clarify ambiguities and consulted additional experts in the field to strengthen their findings.

Quality Assessment and Limitations

This meta-analysis utilized reputable analytical sources and the industry-standard GRADE profile to evaluate the quality of the study data included. However, potential limitations were noted, including financial support from pHF manufacturers, which was not fully disclosed, raising concerns about possible bias in the results. Additionally, some studies had small sample sizes.

Conclusion and Future Research

In conclusion, although the evidence is not definitive, it suggests that pHF formulas may reduce the risk of allergies in infants, particularly eczema. Further research is essential to identify which infants may benefit most from this type of formula.

About the Author

Written by Susan Mercer Hinrichs, MA, MBA, CPhT.

Reference

A Partially Hydrolyzed 100% Whey Formula and the Risk of Eczema and Any Allergy: An Updated Meta-Analysis. Authors: Hania Szajewska and Andrea Horvath, both affiliated with the Medical University of Warsaw, Poland, Department of Pediatrics.